No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on
                         Fenofibrate-induced Hepatocarcinogenesis in Rats by Nishimura, Jihei et al.
J Toxicol Pathol 2009; 22: 255–261
Original
No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on 
Fenofibrate-induced Hepatocarcinogenesis in Rats
Jihei Nishimura1,2, Yasuaki Dewa1,2, Meilan Jin3, Yukie Saegusa1,2, 
Masaomi Kawai1,2, Sayaka Kemmochi1,2, Keisuke Shimamoto1,2, 
Tomoaki Harada1, Tadashi Itoh4, Tomomi Shima1, Makoto Shibutani1, and 
Kunitoshi Mitsumori1
1Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3–5–8 Saiwai-cho, Fuchu-shi, 
Tokyo 183-8509, Japan
2Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1–1 Yanagido, Gifu-
shi, Gifu 501-1193, Japan
3Division of Pathology, National Institute of Health Sciences, 18–1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
4Hashima Laboratory, Nihon Bioresearch Inc., 104, 6-Chome, Majima, Fukuju-cho, Hashima, Gifu 501-6251, Japan
Abstract:  To clarify the modifying effect of N-Acetyl-L-Cysteine (NAC), which has antioxidative ability, on
hepatocarcinogenesis promoted by fenofibrate (FF), a peroxisome proliferator-activated receptor (PPAR) alpha agonist
, male F344/N rats were administered a single intraperitoneal injection of N-diethylnitrosamine (DEN) as an initiator
followed by administration of a diet containing 3,000 ppm of FF for 16 weeks.  Two-thirds partial hepatectomy was
performed 1 week after the FF treatment.  Additionally, NAC treatments for 14 weeks from 2 weeks after the FF
treatment were performed.  Although the expression level of tumor protein p53 (Tp53) mRNA decreased in the
DEN+FF+NAC group as compared with that in the DEN+FF group, no significant differences between the DEN+FF and
DEN+FF+NAC groups were observed in the number of hepatocellular altered foci and activities of hepatocellular
proliferation.  In addition, the results of an antioxidant enzyme assay and measurement of the amounts of total
glutathione in the liver revealed no significant difference between the DEN+FF and DEN+FF+NAC groups; although
no significant differences were observed in many genes between the DEN+FF and DEN+FF+NAC groups, only
glutathione peroxidase 2 (Gpx2) mRNA increased in the DEN+FF+NAC group as compared with the DEN+FF group.
The results under the present experimental conditions indicate no obvious modifying effect of NAC on liver tumor
promotion by FF in rats.  (J Toxicol Pathol 2009; 22: 255–261)
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Introduction
Reactive oxygen species (ROS) induce oxidative
damage in various cell constituents such as DNA, proteins
and lipids through oxidative stress1.  In particular, oxidative
DNA damage causes mutations and abnormal gene
expressions that are involved in carcinogenesis2.  Treatments
with antioxidants or free radical scavengers are a powerful
technique to investigate the involvement of ROS in
chemical-induced acute and chronic injuries and
carcinogenesis.  Nakae et al.3–5 reported that N-tert-Butyl-α-
phenylnitrone (PBN), which is a nitrone-based compound
that traps or scavenges free radical species such as H2O2 and
superoxide anion and has been widely used as a spin trapping
agent in the detection of free radical species, has inhibitory
effects with decreased formation of 8-hydroxyguanine in
DNA on hepatocarcinogenesis model in rats fed a choline-
deficient, L-amino acid-defined (CDAA) diet.  Nishikawa-
Ogawa et al.6 reported that the treatments with N-Acetyl-L-
Cysteine (NAC), which is an analogue of cysteine as well as
a precursor of reduced glutathione (GSH) and plays a role in
enhancing the activities of glutathione S-transferases,
glutathione peroxidase, glutathione reductase, NADH- and
NAD(P)H-quinone reductase, inhibited the development of
GST-P positive foci in the livers of rats treated with 2-
amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in
the post-initiation stage.  NAC has also been reported to
decrease significantly the incidences of neoplastic and
preneoplastic lesions in many organs, including the liver,
induced by a variety of chemical carcinogens in rodents7.  As
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mentioned above, antioxidants are reported to be useful in a
number of ways with regards to inhibition of tumor
formation.  Some studies have also shown that patients with
virus-mediated hepatocellular carcinomas have lower levels
of anti-oxidants in their blood and livers8.
Fenofibrate (FF), a member of the fibrate class of
hypolipidemic drugs, has been extensively used in many
countries to treat hypertriglyceridemia and mixed
hyperlipidemia9.  It belongs to the broad class of chemicals
known as peroxisome proliferators (PPs), which act through
the peroxisome proliferator activated receptor α (PPARα).
Information about FF have been released by the U.S. Food
and Drug Administration (FDA) that shows FF to be
carcinogenic to rodent species when administered at high
doses; 200 mg/kg of FF administered to rats for 24 months or
to mice for 21 months increased the incidence of
hepatocellular carcinomas in both sexes.  However, FF
showed no mutagenic potential in the following four tests:
Ames, mouse lymphoma, chromosomal aberration and
unscheduled DNA synthesis.  Rusyn et al.10 have shown that
the treatment with Wy-14643, a known rodent nongenotoxic
carcinogen and a PP, to mice for 1 month significantly
increased the expression levels of base excision DNA repair
genes with no change of commonly used indicators such as
8-oxoguanine and abasic sites in the liver DNA of control
and Wy-14643-treated mice.  We have also recently
identified changes that indicate DNA damage, such as
elevations of 8-hydroxydeoxyguanosine (8-OHdG) and
expression of DNA repair enzymes, in the livers of rats in the
early stage of repeated FF toxicity and during the
preneoplastic foci formation stage, which is linked to
oxidative stress11,12.  On the other hand, there are some
studies reporting little or no change in the markers of
oxidative DNA damage (e.g., 8-OHdG) in response to
PPs13,14.
Therefore, in the present study, to clarify the possible
mechanism of the oxidative stress-mediated liver tumor
promoting effect in rats given FF in greater detail, we
performed preliminary experiments using a two-stage
hepatocarcinogenesis model in N-diethylnitrosamine
(DEN)-initiated rats given simultaneously both FF and NAC
and investigated the modifying effect of NAC on liver tumor
promotion induced by FF.
Materials and Methods
Chemicals
FF (purity, >99%) was purchased from Sigma-Aldrich
Chemical Co. (St. Louis, MO, USA).  NAC (purity, >98%)
and DEN (purity, >99%) were purchased from Wako Pure
Chemical Industries (Osaka, Japan) and Tokyo Kasei Kogyo
(Tokyo, Japan).  All other chemicals were of analytical grade
and obtained commercially.
Animals and chemicals
A total of 8 male 5-week-old F344/N Slc rats were
purchased from Japan SLC Inc. (Shizuoka, Japan).  The rats
were housed in stainless steel cages with 4 animals per cage
and allowed ad libitum access to tap water and a commercial
powdered basal diet (MF; Oriental Yeast Industries Co.,
Ltd., Tokyo, Japan).  All the animals were handled under
standard conditions (room temperature, 23 ± 3 °C; relative
humidity, 55 ± 15%; 12-h light and dark cycle).  The rats
were acclimatized for 1 week before treatment with N-
diethylnitrosamine (DEN; Sigma-Aldrich Chemical Co., St.
Louis, MO, USA).  Animal care and experiments were
carried out in accordance with the Guide for Animal
Experimentation of the Tokyo University of Agriculture and
Technology.
Experimental design
The experimental design is shown in Fig. 1.  In this
preliminary experiment, we used a 2-stage liver
carcinogenesis model of rats.  After acclimatization, all the
animals underwent i.p. injection of DEN (200 mg/kg body
weight) dissolved in saline to initiate hepatocarcinogenesis.
After 2 weeks, the rats were divided into 2 tests group,
consisting of the DEN + FF (4 animals) and DEN + FF +
NAC (4 animals) groups, using stratification methods based
on body weight on the day before the FF treatment.
Beginning on the next day, the groups were fed a diet
containing 3,000 ppm FF for 16 weeks; in addition, the DEN
+ FF + NAC group was given 3,000 ppm NAC in their water
over the period of 2 to 16 weeks after the FF treatment.  All
rats were subjected to two-thirds partial hepatectomy 1 week
after the FF treatment.  The dosage of FF in this study was
selected based on the results of our previous study12.  With
respect to NAC, Nishikawa-Ogawa et al. demonstrated an
inhibitory effect on MeIQx rat hepatocarcinogenesis using
NAC at a dosage of 100 mg/kg body weight by intragastric
administration five times/week6.  In addition, in Swiss albino
mice treated with a single i.p. injection of urethane (1 g/kg
body weight), administration of 2,000 ppm NAC in the diet
(200 mg/kg body weight) significantly decreased both the
incidence and multiplicity of lung tumors15.  In A/J mice
treated with a single i.p. injection of urethane (0.25 g/kg
body weight), administration of 2,000 ppm NAC in the diet
significantly decreased the multiplicity of lung tumors16.  On
the other hands, Badawy et al. reported that administration
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of NAC at a dosage of 600 mg/kg/body weight induced liver
dysfunction and damage in adult male rats17.  Therefore, in
the present study, we selected 3,000 ppm NAC as an
approximate dosage in drinking water, which is equivalent to
300 mg/kg body weight NAC17.  Body weight, food
consumption and water intake were measured once a week.
Necropsy was performed under anesthesia with ether at the
end of week 8 after fasting for 16 h.  All the remaining lobes
of the livers were removed and weighed.  The liver samples
were sectioned, and one section was used for
histopathological examinations, while the other sections
were frozen in liquid nitrogen and stored at –80°C for future
analyses.  For light microscopy, formalin-fixed liver tissues
were embedded in paraffin, and tissue slices were sectioned.
Hematoxylin and eosin (H&E) staining was performed for
the sections in accordance with procedures for the routine
histopathological examinations.
Immunohistochemical staining for Ki-67 and GST-P
Immunohistochemical staining for Ki-67 and
glutathione S-transferase placental form (GST-P) was
conducted to evaluate cell proliferation and quantitatively
analyze of hepatocellular preneoplastic lesions, respectively.
Sections for Ki-67 were heated using an autoclave in citrate
buffer for antigen retrieval and subjected to
immunohistochemistry with a mouse monoclonal antibody
against Ki-67 (1:30; clone MIB-5; DAKO Japan, Kyoto,
Japan) using the horseradish peroxidase-avidin-biotin
complex method and a Histofine SAB-PO Kit (Nichirei,
Tokyo, Japan), with 3,3-diaminobenzidine/H2O2 as the
chromogen.  Sections for GST-P were subjected to
immunohistochemistry with a rabbit polyclonal antibody
against GST-P (1:2000; Medical & Biological Laboratories,
Aichi, Japan) using the horseradish peroxidase-avidin-biotin
complex method and a Vectastain Elite ABC kit (Vector
Laboratories Inc., Burlingame, CA, USA), with 3,3-
diaminobenzidine/H2O2 as the chromogen.  The sections
were counterstained with hematoxylin for microscopic
observation.  The numbers and areas of GST-P positive foci
(>0.2 mm in diameter) and total areas of the liver sections
were measured using the Scion Image software (Scion Corp.,
Frederick, MD, USA).  The labeling index of Ki-67 was
expressed as the percentage of positive cells after counting
approximately 5,000 hepatocytes in 10 fields (×100) selected
randomly in each specimen.
Determination of enzyme activities
The rat liver tissue used for the enzyme assay was
homogenized in 10 mM of ice-cold Tris-HCl (pH 7.4)
containing 0.25 M sucrose and 1 mM EDTA using an all-
glass Potter Elvehjem homogenizer.  Each homogenate was
centrifuged for 20 min at 800 ×g.  The resulting supernatant
fraction was used to determine the enzyme activities of
carnitine palmitoyltransferase (CPT), fatty acyl-CoA
oxidizing system (FAOS), superoxide dismutase (SOD) and
catalase.  Protein concentrations (mg/mL) were determined
using a BCA Protein Assay Kit (Pierce Biotechnology, IL,
USA).  CPT involved in mitochondrial β-oxidation was
measured spectrophotometrically by the methods of
Markwell et al.18 following the release of a CoA-SH from
acetyl-CoA and palmitoyl-CoA each, using the general thiol
reagent DTNB (5,5’-dithio-bis-(2-nitrobenzoic acid)).
FAOS involved in peroxisomal β oxidation was measured
spectrophotometrically by the methods of Markwell et al.18.
Activity was defined as μmol per min per mg protein.  The
superoxide dismutase (SOD) and catalase levels were
determined using an SOD Assay Kit-WST (Dojindo
Molecular Technologies, Inc., Gaithersburg, MD, USA) and
Amplex Red Catalase Assay Kit (Molecular Probes, Inc.,
Eugene, OR, USA), respectively, according to the
manufacturer’s protocol.  Activity was defined as units per
mg protein.
A liver tissue sample was also deproteinated by the
addition of trichloroacetic acid, and DTNB [5,5-dithiobis(2-
nitrobenzoic acid)] was added to supernatants cleared by
centrifugation (10 min, 800 ×g).  The formation of 5-thio-2-
nitrobenzoic acid, which is proportional to the total GSH
concentration, was monitored at 412 nm against reagent
controls19.  GSH are expressed as mg per g of wet hepatic
tissue. 
RNA isolation and gene expression analyses
Total RNA was isolated from 4 animals of each group
using TRIzol reagent (Invitrogen Corp., Carlsbad, CA,
USA) according to the manufacturer’s protocol.
Quantitative real-time RT-PCR analyses with the SuperScrip
III First-Strand Synthesis System (Invitrogen Corp.,
Carlsbad, CA, USA) and SYBR green PCR master mix
(Applied Biosystems, Foster City, CA, USA) using an ABI
Prism 7000 Sequence Detection System (Applied
Biosystems) were carried out using the abovementioned 4
RNA samples of each group.  Taking into account the
finding of our previous reports11,12, we assessed the gene
expressions of the following 25 genes: acyl-Coenzyme A
oxidase 1 (Aco), cytochrome P450, 4A1 (Cyp4a1), acetyl-
coenzyme A acetyltransferase 1 (Acat1), glutathione
peroxidase 2 (Gpx2), growth arrest and DNA-damage-
inducible 45 alpha (Gadd45a), UDP glycosyltransferase 1
family, polypeptide A6 (Ugt1a6), glutathione S-transferase
Yc2 subunit (Yc2), catalase (Cat), glutathione S-transferase,
mu 2 (Gstm2), glutathione S-transferase, mu 3 (Gstm3),
glutathione-S-transferase, alpha type 2 (Gsta2), cytochrome
P450, family 1, subfamily a, polypeptide 2 (Cyp1a2),
apurinic/apyrimidinic endonuclease 1 (Apex1), X-ray repair
complementing defective repair in Chinese hamster cells 5
(Xrcc5), O-6-methylguanine-DNA methyltransferase
(Mgmt), MutL homolog 1 (Mlh1), topoisomerase (DNA) I
(Top1), nibrin (Nbn), 8-oxoguanine-DNA-glycosylase
(Ogg1), cyclin D1 (Ccnd1), tumor protein p53 (Tp53),
cyclin-dependent kinase inhibitor 1B (Cdkn1b), checkpoint
kinase 2 homolog (Chek2), growth arrest and DNA-damage-
inducible 45 beta (Gadd45b) and cyclin-dependent kinase
inhibitor 1A (Cdkn1a).  To obtain the relative quantitative
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endogenous control, and its expression levels were
calculated according to the 2-ΔΔCt method20.  The primers
used in the present study were identical to those of our
previous studies11,12.
Statistical evaluation
Statistical analyses were performed using statistical
software (StatLight; Yukms Co., Ltd., Japan), and all results
are presented as means ± SD.  The 2 corresponding groups
were compared by analyzing the data using the F-test for
homogeneity of variance between the DEN+FF and
DEN+FF+NAC groups.  If the variance was homogeneous,
the student’s t-test was applied for comparisons, and if it was
heterogeneous, the Aspin-Welch’s t-test was used.  A P
value of less than 0.05 was considered statistically
significant.
Results
Data for final body weight, food intake, FF intake,
water intake, antioxidant intake and liver weight of the rats
given FF with or without NAC treatments are shown in
Table 1.  There was no significant difference in above
parameters between the DEN+FF and DEN+FF+NAC
groups.
Histopathologically, hepatocellular altered foci were
found in the livers of both groups, but their numbers were
almost the same in the two groups (Fig. 2).  In addition,
immunohistochemical examinations for GST-P showed no
changes of the number and area of GST-P positive foci
between the two groups.  There was no significant difference
in the activity of hepatocellular proliferation between the
DEN+FF and DEN+FF+NAC groups (Table 1, Fig. 2).
The results of examination of enzyme activities and the
amounts of total GSH are shown in Table 2.  The activities of
enzymes, such as CPT, FAOS, SOD and catalase, and the
amount of total GSH showed no significant differences
between the DEN+FF and DEN+FF+NAC groups.
The results of real-time RT-PCR are shown in Table 3.
Overexpression of Gpx2 mRNA and underexpression of
Tp53 mRNA were observed in the DEN+FF+NAC group
with statistical significances as compared with the DEN+FF
group.  The expression levels of other genes in the
DEN+FF+NAC group were not significantly different from
those in the DEN+FF group.
Discussion
It is well known that oxidative stress has an important
role in chemical carcinogenesis21.  NAC is a widely used
thiol-containing antioxidant that is a precursor of reduced
GSH and also affects many ROS-mediated signaling
pathways such as c-Jun N-terminal kinase, p38 MAPK,
redox-sensitive activator protein-1 and NF-κB22,23.  With
respect to the inhibitory effect of treatment with NAC on
liver tumors, Nishikawa-Ogawa et al. reported that
intragastric administration of dose of 100 mg/kg body
weight doses of five times/week exerted inhibitory effects on
MeIQx-induced rat hepatocarcinogenesis6.  Therefore, we
anticipated that NAC treatment at a dosage of 3000 ppm,
which is equivalent to 300 mg/kg body weight NAC and
higher than the dose used by Nihikawa-Ogawa et al.6, would
inhibit tumor-promoting activity via the oxidative stress of
FF.  However, in the present study, no significant differences
were observed in the number of hepatocellular altered foci
between the DEN+FF and DEN+FF+NAC groups.  On the
other hand, NAC-induced suppression of oxidation-
mediated carcinogenesis has been described in some mouse
models, such as Atm24 and Trp53 knockout mice25.  Indeed,
these mice showed increased ROS production and/or
compromised antioxidant defense, but NAC treatment
reversed the oxidative DNA damage and the frequency of
DNA deletions in them through refinement of these
decreased functions.  In these experiments, drinking water
containing NAC (40 mM NAC) was given to the mice to
yield an average dose of 1 g NAC per kg body weight per
Table 1. The Effect of Coadministration of NAC on General Findings and the Data for the Liver Weight, GST-P Positive
Foci, and Cell Proliferation in the Livers of Rats Given FF after DEN Initiation
Groups DEN+FF DEN+FF+NAC
Number of rats 4 4
Final body weight (g) 285.0 ± 12.8 286.3 ± 17.4
Food intake (g) a 14.4 ± 1.2 13.8 ± 2.3
Fenofibrate exposure (mg/kg BW/day) 168.4 ± 20.2 163.1 ± 23.4
Water intake (mL) a 20.7 ± 1.9 18.9 ± 3.2
Antioxidant exposure (mg/kg BW/day) 0 245.11 ± 48.4
Absolute liver weight (g) 19.45 ± 1.28 19.84 ± 0.71
Relative liver weight (g) 6.82 ± 0.25 6.94 ± 0.29
Hepatocellular altered foci Number (No./cm2) 10.5 ± 4.5 10.6 ± 3.3 
GST-P positive foci (>0.2 mm) Area (mm2/cm2)0 . 5 5 ± 0.45 0.43 ± 0.28 
Number (No./cm2)3 . 4 7 ± 1.42 4.24 ± 2.50
Ki-67 positive cells (%) 1.15 ± 0.54 2.12 ± 0.59
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day.  In addition, the same intake of NAC has been shown to
reduce DNA-adduct formation in rats exposed to genotoxic
carcinogens and cigarette smoke26.  Considering these
findings, the dose of NAC used in our study may be too low
to exert anti-oxidative effects against the tumor promotion of
FF in the liver.
With respect to the ROS production by treatment with
FF, we have previously reported that FF continuously
exerted increased DNA-damaging effects, such as elevation
of 8-OHdG in liver DNA, and increased the mRNA levels of
DNA repair enzymes in addition to increased fatty acid
oxidation and decreased activities of its eliminating
enzymes, resulting in enhanced tumor promotion in FF-
induced hepatocarcinogenesis11,12.  Thus, increased ROS
production is involved in one of the possible mechanisms of
FF-induced hepatocarcinogenesis in rats.  However, in the
Fig. 2. The effect of coadministration of NAC on the formation of hepatocellular altered foci and cell proliferation in the livers of
rats given FF after DEN initiation.  A: H&E staining in the DEN+FF group.  Bar=1.0 mm.  B: H&E staining in the
DEN+FF+NAC group.  Bar=1.0 mm.  The area indicated by the arrowheads represents a hepatocellular altered focus.  C: Ki-
67 staining in the DEN+FF group.  Bar=200 μm.  D: Ki-67 staining in the DEN+FF+NAC group.  Bar=200 μm.
Table 2. The Effect of Coadministration of NAC on Various Enzyme Activities in the Livers of Rats Given FF
after DEN Initiation
Groups DEN+FF DEN+FF+NAC
Number of rats 4 4
Carnitine palmitoyltransferase activity (μM/min/mg protein) 1.77 ± 0.12 1.74 ± 0.16
Fatty acid oxidizing system activity (μM/min/mg protein) 3.20 ± 0.27 3.04 ± 0.35
Superoxide dismutase activity (Units/mg protein) 13.7 ± 0.7 14.6 ± 0.9
Catalase activity (Units/mg protein) 2074 ± 173 1966 ± 378
Total glutathione (mg/g liver) 4.2 ± 1.7 3.0 ± 0.3
Values are expressed as means ± S.D.260 Effect of NAC on FF-induced Hepatocarcinogenesis
present study, although the change observed in the
DEN+FF+NAC group was a significant, but slight, increase
in the expression level of Gpx2 mRNA, there were no
significant changes in the expression levels of other
metabolic stress- and DNA repair-related genes nor in the
activities of antioxidant enzymes and amount of total GSH in
the liver in this group.  Additionally, supplementation of
NAC in the promotion stage of FF produced no significant
differences in the activity of tumor promotion between the
DEN+FF and DEN+FF+NAC groups, although a decreased
expression level of Tp53 mRNA was observed in the
DEN+FF+NAC group as compared with the DEN+FF
group.  It is known that GPX2, which is a potent detoxifier of
ROS, is up-regulated in cancer cells and colitis, and
intestinal cancers are induced in Gpx1/Gpx2 double
knockout mice27.  In cells having TP53, DNA damage-
inducing treatment results in a rapid accumulation of TP53
protein28,29, which can lead to induction of apoptosis.  Yan et
al. reported that up-regulation of GPX2 inhibits activation of
TP53 by reducing the extent of oxidative stresses and
oxidative stress-induced apoptosis in a p53-dependent
manner30.  Considering these findings, the increased Gpx2
and decreased Tp53 mRNA observed in the present study
may indicate the reduction of oxidative stresses, although the
reduction is slight.  The reason why NAC treatment was
performed from 2 weeks after the FF treatments in our study
(or 1 week after the PH) was that this design could omit the
influences of NAC on the liver regeneration induced after
PH so that we could evaluate only the anti-promoting effects
of NAC on liver tumor promotion by FF.  Additional studies
using higher doses of NAC may show inhibitory effects of
NAC on FF-induced hepatocarcinogenesis.
In conclusion, our data from the present study did not
demonstrate an obvious inhibitory effect of NAC on liver
tumor promotion in rats induced by FF.  This finding
suggests that the anti-oxidative activity of the NAC used in
the present study may be too low to exert anti-oxidative
effects against tumor promotion by FF in the liver.
Additional investigation with a different experimental
design is now in progress to clarify further the possible
mechanism of tumor promotion in FF-induced
hepatocarcinogenesis in rats.
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